Individual double‐blind RCT of metformin + liraglutide versus metformin + placebo among women with GDM within 12 months, BMI ≥25 kg/m2, and abnormal oral glucose tolerance test. The primary outcome was change in insulin secretion‐sensitivity index. This evidence concerns the gene INS and gestational diabetes.